Avalon GloboCare Corp. (NASDAQ:CHGA) Stock Short Interest Report for September

Avalon GloboCare Corp. (NASDAQ:CHGA) was the target of a significant growth in short interest during the month of September. As of September 30th, there was short interest totaling 85,127 shares, a growth of 156.5% from the September 15th total of 33,188 shares. Currently, 9.1% of the shares of the stock are short sold. Based on an average daily volume of 3,006,731 shares, the days-to-cover ratio is currently 0.0 days.

Avalon GloboCare Price Performance

CHGA stock traded up $0.08 during trading on Monday, reaching $2.10. 151,867 shares of the stock traded hands, compared to its average volume of 362,469. The firm has a market capitalization of $2.35 million, a PE ratio of -0.15 and a beta of -0.08. The business’s 50 day moving average price is $3.38 and its 200-day moving average price is $5.96. Avalon GloboCare has a 52-week low of $1.79 and a 52-week high of $48.00.

Avalon GloboCare (NASDAQ:CHGA) last released its quarterly earnings data on Friday, August 14th. The company reported ($2.80) EPS for the quarter.

Wall Street Analyst Weigh In

Separately, Weiss Ratings upgraded shares of Avalon GloboCare from a “sell (e)” rating to a “sell (e+)” rating in a report on Monday, August 24th. One equities research analyst has rated the stock with a Sell rating. According to MarketBeat.com, Avalon GloboCare has a consensus rating of “Sell”.

Avalon GloboCare Company Profile

Avalon GloboCare Corp. is a biotechnology company focused on developing cell-based and regenerative medicine technologies. Its work has included cellular immunotherapies, exosome-based products and other platforms intended to support the treatment of cancer and other serious medical conditions.

The company has also pursued activities involving cell and gene therapy development, biobanking and related laboratory services. Avalon GloboCare has described its business as spanning research, product development and potential commercialization through collaborations and strategic partnerships.

Avalon GloboCare was founded in the United States and has historically been associated with operations in New Jersey.